C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
167/211, 260/243
C07D 413/06 (2006.01) A61K 31/535 (2006.01) A61K 31/54 (2006.01) C07D 265/36 (2006.01) C07D 279/16 (2006.01) C07D 413/12 (2006.01) C07D 417/06 (2006.01) C07D 417/12 (2006.01) C07D 451/04 (2006.01) C07D 451/14 (2006.01) C07D 453/02 (2006.01)
Patent
CA 2020315
ABSTRACT OF THE DISCLOSURE A benzazine compound, a geometrical isomer of said benzazine compound, an optical isomer of said benzazine compound, and a pharmaceutically acceptable salt of said benzazine compound, said benzazine compound being represented by formula (I): Image wherein each symbol is as defined in the specification. Said benzazine compounds exhibit 5-HT3 receptor antagonistic activity, and 5-HT1A receptor and/or dopamine D2 receptor blocking activity so that they are useful as drugs for the prophylaxis or treatment of various digestive diseases vomiting and disturbances in central nervous systems and the like. The intermediates for said benzazine compounds are also disclosed.
Fukuda Takemi
Ikezawa Ryuhei
Kawakita Takeshi
Kuroita Takanobu
Riches Mckenzie & Herbert Llp
Yoshitomi Pharmaceutical Industries Ltd.
LandOfFree
Benzazine compounds and pharmaceutical uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzazine compounds and pharmaceutical uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzazine compounds and pharmaceutical uses thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1412363